The nuclear export signal-dependent localization of oligonucleopeptides enhances the inhibition of the protein expression from a gene transcribed in cytosol
- PMID: 10373590
- PMCID: PMC148482
- DOI: 10.1093/nar/27.13.2730
The nuclear export signal-dependent localization of oligonucleopeptides enhances the inhibition of the protein expression from a gene transcribed in cytosol
Abstract
Upon endocytosis, most oligodeoxynucleotides (ODNs) accumulate in vesicular compartments; a tiny number of them cross the vesicle membrane, reach the cytosol and by passive diffusion enter the nucleus where they are entrapped. So far, the compartment in which an antisense ODN interacts with its mRNA target has not been precisely characterized. In an attempt to answer this question, ODN-peptides were designed with the aim of maintaining them in the cytosol. This has been achieved by a short peptide sequence called the nuclear export signal (NES). Upon microinjection, ODN-NES peptide conjugates were efficiently and rapidly exported from the nucleus to the cytosol whereas ODN-peptides containing an inactive NES were found to be located in the nucleus. The inhibitory activity of antisense ODN was tested in a system allowing the specific transcription of a luciferase reporter gene in the cytosol. Antisense propynylated ODN-NES peptide conjugates, directed against the luciferase gene, efficiently inhibited (75%) the cytosolic expression of luciferase whereas at the same concentration the peptide-free propynylated ODN or the propynylated ODN-peptides containing an inactive NES were nearly inactive.
Similar articles
-
Highly sensitive inhibition of hTERT mRNA expression and telomerase activity by DNA-signal-peptide conjugates.Nucleic Acids Symp Ser (Oxf). 2005;(49):337-8. doi: 10.1093/nass/49.1.337. Nucleic Acids Symp Ser (Oxf). 2005. PMID: 17150771
-
Intracellular routing and inhibitory activity of oligonucleopeptides containing a KDEL motif.Mol Pharmacol. 1997 Mar;51(3):431-8. Mol Pharmacol. 1997. PMID: 9058598
-
Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes.Gene Ther. 2003 Jul;10(13):1105-15. doi: 10.1038/sj.gt.3301966. Gene Ther. 2003. PMID: 12808441
-
Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.Bioconjug Chem. 1995 Jan-Feb;6(1):101-8. doi: 10.1021/bc00031a012. Bioconjug Chem. 1995. PMID: 7711095
-
Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.Biochem Pharmacol. 1999 Jul 1;58(1):95-107. doi: 10.1016/s0006-2952(99)00083-0. Biochem Pharmacol. 1999. PMID: 10403523
Cited by
-
Signal sequences for targeting of gene therapy products to subcellular compartments: the role of CRM1 in nucleocytoplasmic shuttling of the protein switch.Pharm Res. 2007 Nov;24(11):2146-55. doi: 10.1007/s11095-007-9333-1. Epub 2007 Jun 13. Pharm Res. 2007. PMID: 17562146
-
Linear 2' O-Methyl RNA probes for the visualization of RNA in living cells.Nucleic Acids Res. 2001 Sep 1;29(17):E89-9. doi: 10.1093/nar/29.17.e89. Nucleic Acids Res. 2001. PMID: 11522845 Free PMC article.
-
Model system to study classical nuclear export signals.AAPS PharmSci. 2002;4(3):E18. doi: 10.1208/ps040318. AAPS PharmSci. 2002. PMID: 12423067 Free PMC article.
-
Controlling protein compartmentalization to overcome disease.Pharm Res. 2007 Jan;24(1):17-27. doi: 10.1007/s11095-006-9133-z. Epub 2006 Sep 13. Pharm Res. 2007. PMID: 16969692 Review.
-
Controlling subcellular delivery to optimize therapeutic effect.Ther Deliv. 2010 Jul;1(1):169-93. doi: 10.4155/tde.10.8. Ther Deliv. 2010. PMID: 21113240 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources